Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

4.57
Delayed Data
As of Mar 24
 +0.10 / +2.24%
Today’s Change
2.54
Today|||52-Week Range
7.15
-24.96%
Year-to-Date
How I'd Play Biotech Buyout Rumors
Mar 24 / TheStreet.com - Paid Partner Content
Synergy Pharmaceuticals: Approval, Now What?
Mar 13 / MotleyFool.com - Paid Partner Content
How I'd Play Biotech Buyout Rumours
Mar 24 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close4.47
Today’s open4.50
Day’s range4.48 - 4.59
Volume4,878,834
Average volume (3 months)6,181,319
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-9.01%
Earnings growth (this year)+57.52%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book24.68

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.10+1.40%
INSMInsmed Inc+0.16+1.02%
ALDRAlder Biopharmaceuti...+0.65+3.14%
DEPODepomed Inc+0.05+0.34%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$198.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Gary S. Jacob
Senior Vice President-
Clinical Operations
Laura Barrow
Corporate headquarters
New York, New York

Forecasts


Search for Jobs